iPSC-ing into the future of cell therapy: expansion in a hollow-fiber bioreactor

Induced pluripotent stem cell (iPSC)-derived therapies have opened up a new avenue for stem cell research and unique opportunities to shift cell therapy into an allogeneic paradigm. The development of these therapies requires high-quality iPSC banks generated via standardized workflows to minimize starting material bank-to-bank variability.

In this webinar you will learn more about:

• Providing a consistent and tailored environment for iPSC expansion by hollow-fiber perfusion technology
• How to increase GMP compliance and process standardization
• How to close the seed train by scaling down on this automated platform
• How to scale up and out to manufacture high-quality iPSC banks

Speaking from the Cell and Gene Therapy Catapult

Talk: 21st November, 4:00: "iPSC-ing into the future of cell therapy: expansion in a hollow-fiber bioreactor"

Speaker: Molly Tregido, Associate Senior Scientist, Cell and Gene Therapy Catapult